Andrew M. Dahl
SVP, Corporate Controller · Edwards Lifesciences Corp
- 2025
- Sep 14, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew M. Dahl files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Donald E. Bobo Jr. - $8.28M in EW purchases and sales in the last 12 months
- Scott B. Ullem - $3.22M in EW purchases and sales in the last 12 months
- Daveen Chopra - $3.02M in EW purchases and sales in the last 12 months
- Bernard J. Zovighian - $2.01M in EW purchases and sales in the last 12 months
- Wayne Markowitz - $992K in EW purchases and sales in the last 12 months
- Daniel J. Lippis - $752K in EW purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew M. Dahl?
Andrew M. Dahl is a corporate insider, tracked as SVP, Corporate Controller of Edwards Lifesciences Corp (EW). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Andrew M. Dahl submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Andrew M. Dahl been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($98K) across all tracked filings.
